Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yifei Cheng

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
Cellular and Molecular Life Sciences : CMLS|May 19, 2023
CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m<sup>6</sup>A-dependent mannerFeng Qi, Wenyi Shen, Xiyi Wei, et al.
Chinese Medical Journal|July 18, 2023
Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemiaXiangyu Zhao, Haotian Wu, Yifei Cheng, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 14, 2023
Isomerization of DASA Molecules in the Nanopores of Metal-Organic Frameworks: What Determines Its Reversibility?Yongkui Chen, Shuaiqi Gao, Yifei Cheng, et al.
Journal of Biomedical Research|February 27, 2024
Genetic variant in a BaP-activated super-enhancer increases prostate cancer risk by promoting AhR-mediated <i>FAM227A</i> expressionLulu Fan, Hao Wang, Shuai Ben, et al.
Environment International|August 7, 2024
Genetic variants reduced POPs-related colorectal cancer risk via altering miRNA binding affinity and m<sup>6</sup>A modificationMengfan Guo, Shuwei Li, Yifei Cheng, et al.
British Journal of Haematology|April 21, 2018
Comments on the article: 'Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation'- Response to Pan et alYifei Cheng, Yuhong Chen, Chenhua Yan, et al.
Journal of Translational Medicine|April 17, 2024
An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort studyYifei Cheng, Lang Wu, Junyi Xin, et al.
Chinese Medical Journal|May 26, 2026
Comparable survival outcomes for secondary and de novo acute myeloid leukemia after haploidentical hematopoietic stem cell transplantationKehan Zhang, Yingjun Chang, Yuqian Sun, et al.
Patient Preference and Adherence|August 11, 2025
Exploring Melasma Patients' Needs Through Social Media: A Qualitative StudyXinjin Liu, Xu Liu, Yanbing Han, et al.
Chinese Medical Journal|July 9, 2024
Risk factors for positive post-transplantation measurable residual disease in patients with acute lymphoblastic leukemiaYuewen Wang, Guomei Fu, Lanping Xu, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
Cellular and Molecular Life Sciences : CMLS|May 19, 2023
CSNK1D-mediated phosphorylation of HNRNPA2B1 induces miR-25-3p/miR-93-5p maturation to promote prostate cancer cell proliferation and migration through m<sup>6</sup>A-dependent mannerFeng Qi, Wenyi Shen, Xiyi Wei, et al.
Chinese Medical Journal|July 18, 2023
Bridging chimeric antigen receptor T-cell before transplantation improves prognosis of relapsed/refractory B-cell acute lymphoblastic leukemiaXiangyu Zhao, Haotian Wu, Yifei Cheng, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 14, 2023
Isomerization of DASA Molecules in the Nanopores of Metal-Organic Frameworks: What Determines Its Reversibility?Yongkui Chen, Shuaiqi Gao, Yifei Cheng, et al.
Journal of Biomedical Research|February 27, 2024
Genetic variant in a BaP-activated super-enhancer increases prostate cancer risk by promoting AhR-mediated <i>FAM227A</i> expressionLulu Fan, Hao Wang, Shuai Ben, et al.
Environment International|August 7, 2024
Genetic variants reduced POPs-related colorectal cancer risk via altering miRNA binding affinity and m<sup>6</sup>A modificationMengfan Guo, Shuwei Li, Yifei Cheng, et al.
British Journal of Haematology|April 21, 2018
Comments on the article: 'Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation'- Response to Pan et alYifei Cheng, Yuhong Chen, Chenhua Yan, et al.
Journal of Translational Medicine|April 17, 2024
An early-onset specific polygenic risk score optimizes age-based risk estimate and stratification of prostate cancer: population-based cohort studyYifei Cheng, Lang Wu, Junyi Xin, et al.
Chinese Medical Journal|May 26, 2026
Comparable survival outcomes for secondary and de novo acute myeloid leukemia after haploidentical hematopoietic stem cell transplantationKehan Zhang, Yingjun Chang, Yuqian Sun, et al.
Patient Preference and Adherence|August 11, 2025
Exploring Melasma Patients' Needs Through Social Media: A Qualitative StudyXinjin Liu, Xu Liu, Yanbing Han, et al.
Chinese Medical Journal|July 9, 2024
Risk factors for positive post-transplantation measurable residual disease in patients with acute lymphoblastic leukemiaYuewen Wang, Guomei Fu, Lanping Xu, et al.
Pageof 11